In vitro activity of levofloxacin, singly and in combination with rifamycin analogs, against Mycobacterium leprae.
AUTOR(ES)
Dhople, A M
RESUMO
The in vitro susceptibility of Mycobacterium leprae to levofloxacin was studied by using two biochemical parameters to measure the metabolic activity of the organism. Levofloxacin consistently exhibited twofold greater bactericidal activity than ofloxacin, with the MIC being 0.75 microgram/ml. When combined with one of the three rifamycin analogs, synergism was obtained with KRM-1648 and rifabutin but not with rifampin.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=162891Documentos Relacionados
- In vitro activities of 2,2'-bipyridyl analogs against Mycobacterium leprae.
- Inhibitory and bactericidal activities of levofloxacin, ofloxacin, erythromycin, and rifampin used singly and in combination against Legionella pneumophila.
- In vitro and in vivo activities of macrolides against Mycobacterium leprae.
- In vitro activities of aminoglycosides, lincosamides, and rifamycins against Mycobacterium leprae.
- Comparative in vitro activities of 20 fluoroquinolones against Mycobacterium leprae.
